Carlos Vallejos
Overview
Explore the profile of Carlos Vallejos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
420
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Araujo J, Gomez A, Jongh W, Ausejo J, Cordova I, Schwarz L, et al.
Ecancermedicalscience
. 2023 Feb;
17:1494.
PMID: 36816782
Introduction: A high prevalence of advanced breast cancer (BC) is a common scenario in Latin America. In Peru, the frequency of BC at Stages III/IV is ≈50% despite implementation of...
2.
Colonio C, Lecman L, Pinto J, Vallejos C, Pinillos L
Ecancermedicalscience
. 2022 Feb;
15:1336.
PMID: 35211205
Background: There is a large gap in the data on cancer outcomes in Latin America, making it difficult to establish adequate cancer control policies in the region. The aim of...
3.
Aguilar A, Mas L, Enriquez D, Vallejos C, Gutarra R, Flores C
Cancer Control
. 2022 Jan;
29:10732748211068637.
PMID: 35030060
Background: Lung cancer is still a prevalent and fatal neoplasm in developing countries. In the last decades, chemotherapy (CHT) maintenance occupied an important role in the treatment, as well as...
4.
Montenegro P, Pinillos L, Young F, Aguilar A, Tirado-Hurtado I, Pinto J, et al.
Crit Rev Oncol Hematol
. 2020 Nov;
157:103129.
PMID: 33227573
COVID-19 pandemic is the more challenging public health emergency of the century, producing the collapse of health systems and unprecedented levels of morbidity and mortality around the world, especially in...
5.
De La Puente C, Vallejos C, Velasquez M, Soto D, Orellana J
Value Health Reg Issues
. 2018 Apr;
1(2):156-164.
PMID: 29702895
Objective: To evaluate and compare the costs and effectiveness of two alternative stent, drug eluting stent (SF) and bare metal stent (SNF). Material And Methods: Cost-utility analysis based on a...
6.
Raez L, Cardona A, Santos E, Catoe H, Rolfo C, Lopes G, et al.
Lung Cancer
. 2018 Apr;
119:7-13.
PMID: 29656755
Lung cancer is a public health problem worldwide and Latin America (LATAM) cannot escape this reality. This malignant disease has not only a high prevalence in the region, but is...
7.
De La Puente C, Vallejos C, Bustos L, Zaror C, Velasquez M, Lanas F
J Clin Epidemiol
. 2016 Dec;
86:117-124.
PMID: 27989953
Objective: To evaluate the incremental cost-effectiveness ratio (ICER) of the use of ticagrelor as a substitute for clopidogrel for secondary prevention of acute coronary syndrome in Chile. Study Design And...
8.
Rolfo C, Caglevic C, Bretel D, Hong D, Raez L, Cardona A, et al.
ESMO Open
. 2016 Nov;
1(4):e000055.
PMID: 27843620
Latin America and the Caribbean have not yet developed strong clinical cancer research programmes. In order to improve this situation two international cancer organisations, the Latin American Society of Clinical...
9.
Lanas F, Castro C, Vallejos C, Bustos L, De La Puente C, Velasquez M, et al.
J Clin Epidemiol
. 2016 Oct;
86:75-83.
PMID: 27756577
Objective: Nonvalvular atrial fibrillation (NVAF) is a risk factor for ischemic stroke and systemic embolism. New oral anticoagulants are currently available. The objective of this study was to assess the...
10.
Aguilar A, Pinto J, Araujo J, Fajardo W, Bravo L, Pinillos L, et al.
Mol Clin Oncol
. 2016 Jul;
5(2):241-245.
PMID: 27446557
Cervical cancer is the leading malignant neoplasm in Peruvian women. This malignancy is a public health problem and several efforts were previously performed to develop cancer control plans. Geographical, cultural,...